Induction of remission with extended MMX™ mesalamine therapy: time to resolution of UC symptoms

被引：0
|
作者：
Sandborn, W. [1 ]
Kamm, M. [2 ]
Lichtenstein, G. [3 ]
Sumner, M. [4 ]
Joseph, R. [4 ]
机构：
[1] Mayo Clin, IBD Clin, Rochester, MN USA
[2] St Vincents Hosp, Melbourne, Vic, Australia
[3] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA
[4] Shire Pharmaceut Inc, Wayne, PA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 28 条
  • [1] MMX™ mesalamine therapy for the induction of remission beyond 8 weeks:: How long before symptom resolution?
    Sandborn, William
    Kamm, Michael
    Lichtenstein, Gary
    Sumner, Michael
    Joseph, Raymond
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S435 - S435
  • [2] MMX mesalamine for maintaining remission of ulcerative colitis (UC): Interim safety results
    Lichtenstein, Gary R.
    Butler, Todd
    Barrett, Karen
    Stephenson, David
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S433 - S433
  • [3] The Effect of Ulcerative Colitis (UC) Remission Status Aft er Induction With MMX® Mesalamine on Long-Term Maintenance Therapy Outcomes (MOMENTUM Study): Induction Phase Results
    Rubin, David
    D'Haens, Geert
    Inglis, Susi
    Magee, Elizabeth
    Solomon, Dory
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S676 - S676
  • [4] Time to initial symptom resolution with MMX™ mesalamine therapy for active, mild-to-moderate ulcerative colitis
    Sandborn, William J.
    Karlstadt, Robyn
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S462 - S463
  • [5] Comparison of Long-term Outcomes of MMX Mesalamine Maintenance Treatment for Ulcerative Colitis (UC) between Patients (Pts) in Complete Remission (CR) and Partial Remission (PR) Following Induction
    Rubin, David
    Inglis, Susi
    Magee, Elizabeth
    Streck, Paul
    Solomon, Dory
    D'Haens, Geert
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S545 - S545
  • [6] Effect of Extended MMX Mesalamine Therapy for Acute, Mild-to-Moderate Ulcerative Colitis
    Kamm, Michael A.
    Lichtenstein, Gary R.
    Sandborn, William J.
    Schreiber, Stefan
    Lees, Kirstin
    Barrett, Karen
    Joseph, Raymond
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 1 - 8
  • [7] Satisfaction with therapy among patients treated with MMX™ mesalamine for maintenance of remission in patients with mild-to-moderate ulcerative colitis
    Sandborn, W.
    Lichtenstein, G.
    Kamm, M.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [8] Use of High Resolution Anorectal Manometry in UC Patients in Remission With Persistent Anorectal Symptoms
    Parada Elias, San Vicente
    Martinez Marina, Gonzalez
    Zavala Arturo, Mayoral
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S26 - S26
  • [9] Induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis in patients treated with MMXΘ mesalamine: established versus newly diagnosed disease
    Kamm, M.
    Sandborn, W.
    Lichtenstein, G.
    Solomon, D.
    Karlstadt, R.
    Barrett, K.
    Abhyankar, B.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S34 - S34
  • [10] Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Boddu, Prabhakar
    Gubergrits, Natalya
    Lyne, Andrew
    Butler, Todd
    Lees, Kirstin
    Joseph, Raymond E.
    Sandborn, William J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 95 - 102
123